Medical Device News Magazine

Bentley Launches the BeBack Crossing Catheter | Its 1st Product in the United States

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • After the acquisition of the GoBack catheter back in September 2022, Bentley worked behind the scenes on the rebranding of the device from GoBack to BeBack, making sure the device can benefit from the Bentley corporate branding.

Bentley, a global leader in the endovascular treatment for aortic and peripheral vascular disease, announces their first product launch in the United States with the BeBack crossing catheter designed for the treatment of heavily calcified lesions.

After the acquisition of the GoBack catheter back in September 2022, Bentley worked behind the scenes on the rebranding of the device from GoBack to BeBack, making sure the device can benefit from the Bentley corporate branding. Bringing the BeBack to the market marks an important milestone for the German based company since this is the first product, which is launched for the US market.

The BeBack catheter is designed for steering through Chronic Total Occlusions (CTO) that often is the most challenging part when treating heavily calcified lesions. The catheter is available in an 80 and 120 cm catheter in both a 2.9F and 4F size. The device makes use of a steerable and in length adjustable Nitinol needle, which is used for crossing and targeted re-entry purposes. A radiopaque marker indicates the direction in which the curved needle, located near the tip of the catheter, protrudes. Multiple treatment options from antegrade, retrograde and crossover are possible with the BeBack crossing catheter for intraluminal and sub intimal approaches of stenotic or occluded lesions.

Dr. Beasley – vascular and interventional radiologist at Palm Vascular Centers Miami Beach, had the honor to use the first BeBack on US soil. “Now that the BeBack is available I use it more frequently compared to other re-entry devices that are available on the market. The unique features of the BeBack make the most complex lesions easy to cross, and therefore the device helps to reduce the procedure time,” Dr. Beasley said. “Reducing the procedure time is of huge benefit for both the clinical center, the physician and of course for the patients, who will benefits the most. This and the unique features makes the BeBack such a game changer for CTO procedures,” Dr. Beasley continued.

The BeBack crossing catheter is now commercially available nationwide. The device will be showcased and presented at several upcoming conferences both nationally and internationally.

The BeBack is CE marked and FDA cleared for commercial purposes.

For product availability and further information, check: www.bentley.global or send an email to: info@bentley.global.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.